No paralogue variants have been mapped to residue 87 for KCNJ2.
| KCNJ2 | INVGEKGQ--RYLADIFTTCVDIRWRWMLV>I<FCLAFVLSWLFFGCVFWLIALLHGDLDAS- | 116 |
| KCNJ1 | GNVEA-QSRFIFFVDIWTTVLDLKWRYKMT>I<FITAFLGSWFFFGLLWYAVAYIHKDLPEF- | 112 |
| KCNJ3 | GNLGSETS--RYLSDLFTTLVDLKWRWNLF>I<FILTYTVAWLFMASMWWVIAYTRGDLNKA- | 115 |
| KCNJ4 | ANLSNKSQ--RYMADIFTTCVDTRWRYMLM>I<FSAAFLVSWLFFGLLFWCIAFFHGDLEAS- | 90 |
| KCNJ5 | GNVQ-ETY--RYLSDLFTTLVDLKWRFNLL>V<FTMVYTVTWLFFGFIWWLIAYIRGDLDHV- | 121 |
| KCNJ6 | GNVR-ETY--RYLTDIFTTLVDLKWRFNLL>I<FVMVYTVTWLFFGMIWWLIAYIRGDMDHI- | 124 |
| KCNJ8 | KNIR-EQG--RFLQDIFTTLVDLKWRHTLV>I<FTMSFLCSWLLFAIMWWLVAFAHGDIYAY- | 104 |
| KCNJ9 | GNVR-ETY--RYLTDLFTTLVDLQWRLSLL>F<FVLAYALTWLFFGAIWWLIAYGRGDLEHL- | 92 |
| KCNJ10 | EHIADKRF--LYLKDLWTTFIDMQWRYKLL>L<FSATFAGTWFLFGVVWYLVAVAHGDLLEL- | 99 |
| KCNJ11 | KNIR-EQG--RFLQDVFTTLVDLKWPHTLL>I<FTMSFLCSWLLFAMAWWLIAFAHGDLAP-- | 102 |
| KCNJ12 | ANMDEKSQ--RYLADMFTTCVDIRWRYMLL>I<FSLAFLASWLLFGIIFWVIAVAHGDLEPA- | 115 |
| KCNJ13 | DGAQR-GL--AYLRDAWGILMDMRWRWMML>V<FSASFVVHWLVFAVLWYVLAEMNGDLELDH | 89 |
| KCNJ14 | VNLGGQGA--RYLSDLFTTCVDVRWRWMCL>L<FSCSFLASWLLFGLAFWLIASLHGDLAAP- | 121 |
| KCNJ15 | DKVDGIYL--LYLQDLWTTVIDMKWRYKLT>L<FAATFVMTWFLFGVIYYAIAFIHGDLEPG- | 98 |
| KCNJ16 | KHIFGEWG--SYVVDIFTTLVDTKWRHMFV>I<FSLSYILSWLIFGSVFWLIAFHHGDLLND- | 105 |
| cons | > < |
| Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
|---|---|---|---|---|---|
| p.I87V | c.259A>G | Putative Benign | SIFT: Polyphen: |